InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,634.80
(
0.80%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.91
(
0.54%
)
Bitcoin
60,282.09
(
-2.81%
)
Post# of 177
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: DewDiligence post# 102

Wednesday, 12/15/2010 1:39:15 AM

Wednesday, December 15, 2010 1:39:15 AM

Post# of 177

VRUS is not the first company to test an HCV drug with ribavirin without interferon. Idera has been doing it since 2009 (http://clinicaltrials.gov/ct2/show/NCT00990938 ), and Coley Pharmaceuticals (acquired by PFE) did it several years ago.




I stand corrected in my wording. Idera is trying to replace interferon with another immune boosting agent. I'm not familiar with Coley's program but I assume it was similar in nature.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up